Bellafill® To Replace ArteFill® As New Brand

- ArteFill® dermal filler changes name to Bellafill® in the U.S.

- Bellafill® is FDA-approved for the correction of facial wrinkles known as nasolabial folds, or smile lines

News provided by

Dec 01, 2014, 11:00 ET

SAN DIEGO, Dec. 1, 2014 /PRNewswire/ -- Suneva Medical, Inc., a privately-held aesthetics company, today announced that ArteFill®, a dermal filler, has been rebranded as Bellafill® in the U.S.

"We feel that the brand Bellafill® better embodies the transformational outcomes this unique product can provide to our customers and their patients," said Suneva Medical's Chairman and Chief Executive Officer, Nicholas L. Teti, Jr. "In addition, Suneva will build and invest in Bellafill® to increase awareness for the new brand."

ArteFill(R), a dermal filler, has been rebranded as Bellafill(R) in the U.S.

Bellafill® is approved by the U.S. Food and Drug Administration for the correction of facial wrinkles known as nasolabial folds, or smile lines. Proven safe and effective, the dermal filler is comprised of 80 percent purified bovine collagen with 20 percent polymethylmethacrylate (PMMA) microspheres, and lidocaine. In addition to immediately adding volume to smooth away smile lines, Bellafill® helps skin re-create its own firmer structure for beautiful, younger looking skin and lasting results.^1,2

To learn more about Bellafill® visit www.bellafill.com or follow on Facebook: facebook.com/bellafillglobal and Twitter: @bellafill.

Media interested in speaking with a Suneva Medical representative should contact Melody Demel at 619-234-0345 or [email protected]. For more information on Suneva Medical, visit www.sunevamedical.com.

About Suneva Medical, Inc.

Suneva Medical, Inc. is a privately-held aesthetics company focused on developing, manufacturing and commercializing novel, differentiated products for the general dermatology and aesthetic markets. The company currently markets Bellafill® in the U.S. and Canada; ArteFill® in Korea and Singapore; Regenica® in the U.S. and Canada; and ReFissa® in the U.S. For more information, visit www.sunevamedical.com.

¹Gottfried Lemperle, et. al., ArteFill® Permanent Injectable for Soft Tissue Augmentation: I. Mechanism of Action and Injection Techniques., Aesthetic Plast Surg. 2010 Jun;34(3):264–72.
²Data on file, Suneva Medical Inc.

Video - http://origin-qps.onstreammedia.com/origin/multivu_archive/PRNA/ENR/160886-Suneva_BC_Sizzle_512x288.mp4

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bellafill-to-replace-artefill-as-new-brand-300001850.html

SOURCE Suneva Medical, Inc.